Back to Agenda
Session 1, Part 4: Panel Discussion About Facilitated Regulatory Pathways & Good Regulatory Practice
Session Chair(s)
Paul Dearden
Head, Global Regulatory Policy, Biogen, United Kingdom
Speaker(s)
Donia Al Bastaki
Head of Registration Department, Pharmaceutical & Herbal Medicines Registration , Ministry of Health, Drug and Food Control, Kuwait
Inas Chehimi
Head Regulatory Affairs - Middle East & North Africa, Novartis Pharma Services AG, United Arab Emirates
Bandar Al Hammad, MPHARM
Chief Pharmacist & Director of Veterinary Products Department, Saudi Food and Drug Authority (SFDA), Saudi Arabia
Stuart Russel Walker, PHD
Professor and Consultant, Centre for Innovation In Regulatory Science (CIRS), United Kingdom
Rasha Ziada
EDA Chairman Assistant for Technical Development & Capacity Building Affairs, EDA, Egypt
Ghadeer Al-Sheikh Salem
Head, Originator and Biological Drugs Division, Registration Department, Jordan Food and Drug Administration, Jordan
Hajed M.H Hashan
Deputy of General Director, Gulf Health Council, Saudi Arabia
Have an account?